Scarica l'app Stockscreener
8.53
1.16%
-0.10
Dopo l'orario di chiusura:
8.50
-0.03
-0.35%
Regenxbio Inc Borsa (RGNX) Ultime notizie
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. - GlobeNewswire
TCPC IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages BlackRock TCP Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – TCPC - GlobeNewswire Inc.
Tangible book value per share of REGENXBIO, Inc. – SWB:RB0 - TradingView
RGNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, SKILLED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
RGNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGNX PE Ratio & Valuation, Is RGNX Overvalued - Intellectia AI
RGNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 - PR Newswire
REGENXBIO, Inc. Class Action ReminderRobbins LLP Encourages RGNX Stockholders to Contact the Firm for Information About Their Rights - Sahm
REGENXBIO: CEO Makes Major Sale During Legal Battle While Investors Split - Bitget
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit - ChartMill
REGENXBIO (RGNX) proxy: directors, PwC ratification, option-exchange votes - Stock Titan
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
The Precedent: Federal Circuit Upholds Gene Therapy Host Cell Claims Under 35 U.S.C. § 101 in Regenxbio Inc., Et Al. v. Sarepta Therapeutics, Inc., Et Al. - JD Supra
REGENXBIO Inc. (RGNX) stock price, news, quote and history - Yahoo Finance Australia
Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 - ChartMill
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ROSEN, A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure ... - Bluefield Daily Telegraph
RGNX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: LEVI & KORSINSKY, LLP - Morningstar
REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from Analysts - marketbeat.com
Trading Systems Reacting to (RGNX) Volatility - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines – RGNX - ChartMill
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of REGENXBIO Inc. to Contact the Firm Today! - accessnewswire.com
REGENXBIO joins CureDuchenne community event to advance therapies for Duchenne - Traders Union
Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors - GlobeNewswire
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of REGENXBIO Inc. to Contact the Firm Today! - accessnewswire.com
REGENXBIO Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights - Benzinga
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of REGENXBIO Inc. to Contact the Firm Today! - ACCESS Newswire
RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO Inve - GuruFocus
RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO Investors of Securities Class Action Deadline on April 14, 2026 - PR Newswire
Gene Therapy And US Patent Eligibility Update: REGENXBIO, Inc. v. Sarepta Therapeutics, Inc. - MarketScreener
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 earnings call transcript - MSN
RGNX Stockholders Have Opportunity to Lead REGENXBIO Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Vanguard (RGNX) disaggregates holdings; reports 0 shares after realignment - Stock Titan
RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO ... - Bluefield Daily Telegraph
RGNX Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
RGNX Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 - marketscreener.com
REGENXBIO Inc. $RGNX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
ROSEN, NATIONAL TRIAL LAWYERS, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, NATIONAL TRIAL LAWYERS, Encourages REGENXBIO, Inc. - GlobeNewswire
RGNX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming DeadlinesRGNX - prnewswire.com
RGNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 - marketscreener.com
SUEWALLST, LLP: INSTITUTIONAL RGNX HOLDERS FACE PORTFOLIO LOSSES FROM GENE THERAPY FRAUD - Finviz
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that REGENXBIO Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Momentum Shift: Can REGENXBIO Inc deliver consistent dividendsEarnings Overview Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Panic Selling: Is REGENXBIO Inc impacted by rising ratesQuarterly Trade Review & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
RGNX Shareholder Alert: April 14, 2026 Lead Plaintiff Deadline in REGENXBIO Inc. Securities Class Action Lawsuit -- The Gross Law Firm - Sahm
Stop Loss: Is REGENXBIO Inc impacted by rising ratesWeekly Trade Summary & Weekly High Return Opportunities - baoquankhu1.vn
Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP - Law360
RGNX's Inadequate Risk Disclosures Allegedly Cost Investors $2.40/Share: Levi & Korsinsky, LLP - pharmiweb.com
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):